Therapeutic effect of "Jinshui Liujun" in acute exacerbation of chronic obstructive pulmonary disease: A randomized controlled trial
DOI: 10.23977/medcm.2024.060406 | Downloads: 15 | Views: 621
Author(s)
Ge Li 1, Chenqi Li 2, Yaoyao Wang 2, Fuyu Yao 2, Xue Bai 2
Affiliation(s)
1 Respiratory Department, Guang'anmen Hospital (Baoding), China Academy of Chinese Medical Sciences, Baoding, Hebei, 071000, China
2 Guang'anmen Hospital (Baoding), China Academy of Chinese Medical Sciences, Baoding, Hebei, 071000, China
Corresponding Author
Ge LiABSTRACT
The purpose of this investigation is to assess the therapeutic effectiveness of the "Jinshui Liujun" concoction, with adjustments, in the management of sudden deteriorations in chronic obstructive pulmonary disease (COPD) (characterized by phlegm and blood stagnation blocking the lungs, and a deficiency of qi in the lungs and kidneys) using a randomized controlled trial methodology. The research incorporated 100 individuals identified with acute exacerbations of COPD and categorized as having phlegm and blood stagnation obstructing the lungs, and a deficiency of qi in the lungs and kidneys according to traditional Chinese medicine (TCM). They were arbitrarily partitioned into a treatment cohort (50 instances, receiving "Jinshui Liujun" concoction with alterations) and a control group (50 instances, receiving standard Western medicinal treatment). Participants in the treatment group ingested a daily dosage of "Jinshui Liujun" concoction for a duration of 4 weeks; The control group was administered with a combination of Salmeterol and Fluticasone via inhalation. Primary outcome measures encompass clinical effectiveness, pulmonary function indices (FEV1, FEV1/FVC) and blood gas analysis indices (PaCO2, PaO2). The findings revealed that the overall efficacy rate of the treatment group was 86.0%, which was noticeably higher than that of the control group (70.0%, P < 0.05). The enhancement in FEV1 and FEV1/FVC within the treatment group was more pronounced than that within the control group (P<0.05), and the treatment group also exhibited a more significant improvement in reducing PaCO2 and increasing PaO2 (P<0.05). With regard to safety, the occurrence of adverse reactions in the treatment group was merely 6%, which is considerably lower than the 14% in the control group, and all were minor symptoms that swiftly dissipated. This research indicates that the "Jinshui Liujun" concoction, with adjustments, exhibits substantial clinical effectiveness in the treatment of acute exacerbations of COPD (characterized by phlegm and blood stagnation blocking the lungs, and a deficiency of qi in the lungs and kidneys), effectively ameliorating patients' clinical symptoms, pulmonary function, and blood gas analysis indices, with high safety. This offers novel scientific evidence for the treatment of COPD with TCM and implies that the "Jinshui Liujun" concoction, with modifications, possesses potential application value in the treatment of COPD.
KEYWORDS
"Jinshui Liujun" decoction; acute exacerbation; chronic obstructive pulmonary disease; randomized controlled trial; Therapeutic effectCITE THIS PAPER
Ge Li, Chenqi Li, Yaoyao Wang, Fuyu Yao, Xue Bai, Therapeutic effect of "Jinshui Liujun" in acute exacerbation of chronic obstructive pulmonary disease: A randomized controlled trial. MEDS Chinese Medicine (2024) Vol. 6: 42-48. DOI: http://dx.doi.org/10.23977/medcm.2024.060406.
REFERENCES
[1] Li, Z. C. (2021). Additional administration of Jinshui Liujun decoction with modifications for 50 cases of acute exacerbation of chronic obstructive pulmonary disease with lung and kidney qi deficiency. Guangxi Traditional Chinese Medicine, 44(3), 3.
[2] Xu, L. Y., Chen, W. T., & Yang, B. J. (2019). Clinical observation of Jinshui Liujun decoction in the treatment of chronic obstructive pulmonary disease with lung and kidney qi deficiency. Big Doctor, 4(10), 3.
[3] Xu, Q., & Fan, F. C. (2023). Application of the concept of preventive treatment of disease in the treatment of stable chronic obstructive pulmonary disease. Jiangxi Traditional Chinese Medicine, 54(5), 31-33.
[4] Zhang, Z., Yang, Y. R., Wang, H., Li, J. Q., Li, A. P., & Bai, Z. P., et al. (2023). Effect and mechanism of Jinshui Liujun decoction on airway mucus retention in mice with chronic obstructive pulmonary disease. Modern Journal of Integrated Traditional Chinese and Western Medicine, 32(13), 1753-1761.
[5] Bai, Z. P., Liu, Y., Tan, X. N., Tan, D. B., Deng, X. J., & Li, Z. P., et al. (2019). Effect of Jinshui Liujun decoction on the expression of mucin 5ac and aquaporin 5 in the lung tissue of rats with airway mucus hypersecretion in chronic obstructive pulmonary disease. Chinese Journal of Traditional Chinese Medicine Information, 26(8), 6.
[6] Chen, Z. H., Yuan, Y. L., & Ao, S. H. (2023). Discussion on the application of Jinshui Liujun decoction in chronic obstructive pulmonary disease based on the theory of "mutual generation of metal and water". Yunnan Journal of Traditional Chinese Medicine and Materia Medica, 44(7), 21-22.
[7] Guo, G. Z. (2013). Clinical observation of modified Jinshui Liujun decoction in the treatment of chronic obstructive pulmonary disease. Shanxi Traditional Chinese Medicine, 29(9), 2.
[8] Yue, Q. F., Chen, Y. Q., & Fan, X. S. (2020). Study on the mechanism of action of Jinshui Liujun decoction in the treatment of chronic obstructive pulmonary disease based on network pharmacology. Journal of Nanjing University of Traditional Chinese Medicine, 36(3), 7.
[9] Ma, J. M., & Liu, H. (2022). Treatment of chronic obstructive pulmonary disease with modified Jinshui Liujun decoction. Wisdom Health, 8(15), 3.
[10] Yang, Y. R., Zhang, Z., & Liu, Y. (2023). Effect of Jinshui Liujun decoction on macrophage m1/m2 phenotype differentiation in a mouse model of chronic obstructive pulmonary disease. Guide of Traditional Chinese Medicine, 29(10), 6-11.
[11] Peng, J. Q., Ye, W. X., & Fan, F. C. (2020). Effect of Jinshui Liujun decoction on clinical symptoms and inflammatory response in patients with severe to very severe chronic obstructive pulmonary disease. Chinese Journal of Gerontology, 40(13), 4.
Downloads: | 8498 |
---|---|
Visits: | 476278 |
Sponsors, Associates, and Links
-
MEDS Clinical Medicine
-
Journal of Neurobiology and Genetics
-
Medical Imaging and Nuclear Medicine
-
Bacterial Genetics and Ecology
-
Transactions on Cancer
-
Journal of Biophysics and Ecology
-
Journal of Animal Science and Veterinary
-
Academic Journal of Biochemistry and Molecular Biology
-
Transactions on Cell and Developmental Biology
-
Rehabilitation Engineering & Assistive Technology
-
Orthopaedics and Sports Medicine
-
Hematology and Stem Cell
-
Journal of Intelligent Informatics and Biomedical Engineering
-
MEDS Basic Medicine
-
MEDS Stomatology
-
MEDS Public Health and Preventive Medicine
-
Journal of Enzyme Engineering
-
Advances in Industrial Pharmacy and Pharmaceutical Sciences
-
Bacteriology and Microbiology
-
Advances in Physiology and Pathophysiology
-
Journal of Vision and Ophthalmology
-
Frontiers of Obstetrics and Gynecology
-
Digestive Disease and Diabetes
-
Advances in Immunology and Vaccines
-
Nanomedicine and Drug Delivery
-
Cardiology and Vascular System
-
Pediatrics and Child Health
-
Journal of Reproductive Medicine and Contraception
-
Journal of Respiratory and Lung Disease
-
Journal of Bioinformatics and Biomedicine